Cited by 7Diabetes Treatment and ManagementDiabetes Management and ResearchHyperglycemia and glycemic control in critically ill and hospitalized patients

Risk of infection in older adults with type 2 diabetes with relaxed glycemic control

Open access
Lipska, Kasia J., Gilliam, Lisa K., Lee, Catherine, Liu, Jennifer Y., Liu, Vincent X., Moffet, Howard H., Parker, Melissa M., Zapata, Heidi +1 more·2024·Diabetes Care

Abstract

OBJECTIVE: To compare the risk of hospitalization for infection among patients who achieve intensive versus relaxed glycemic control. RESEARCH DESIGN AND METHODS: This retrospective cohort study included adults age ≥65 years with type 2 diabetes from an integrated health care delivery system. Negative binomial models were used to estimate incidence rates and relative risk (RR) of hospitalization for infections (respiratory; genitourinary; skin, soft tissue, and bone; and sepsis), comparing two levels of relaxed (hemoglobin A1c [HbA1c] 7% to <8% and 8% to <9%) with intensive (HbA1c 6% to <7%) glycemic control from 1 January 2019 to 1 March 2020. RESULTS: Among 103,242 older patients (48.5% with HbA1c 6% to <7%, 35.3% with HbA1c 7% to <8%, and 16.1% with HbA1c 8% to <9%), the rate of hospitalization for infections was 51.3 per 1,000 person-years. Compared with HbA1c 6% to <7%, unadjusted risk of hospitalization for infections was significantly elevated among patients with HbA1c 8% to <9% (RR 1.25; 95% CI 1.13, 1.39) but not among patients with HbA1c 7% to <8% (RR 0.99; 95% CI 0.91, 1.08), and the difference became nonsignificant after adjustment. Across categories of infections, the adjusted RR of hospitalization was significantly higher among patients with HbA1c 8% to <9% only for skin, soft tissue, and bone infection (RR 1.33; 95% CI 1.05, 1.69). CONCLUSIONS: Older patients with type 2 diabetes who achieve relaxed glycemic control levels endorsed by clinical guidelines are not at significantly increased risk of hospitalization for most infections, but HbA1c 8% to <9% is associated with an increased risk of hospitalization for skin, soft tissue, and bone infections.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc24-1612

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Elevated glucose levels (>180 mg/dL [>10 mmol/L]) increase risks of dehydration, weakness, infection, poor wound healing, and hyperglycemic crises.

    “elevated glucose levels (>180 mg/dL [>10 mmol/L]) increase risks of dehydration, weakness, infection, poor wound healing, and hyperglycemic crises”

    From 13. Older Adults: Standards of Care in Diabetes—2026 (2026) · cites this paper as [74]

    The Conclusions (page not supplied) state that hyperglycemia increases susceptibility to infection, and report higher hospitalization risk for skin, soft-tissue, and bone infections at HbA1c 8% to <9%. The paper does not establish a glucose threshold of >180 mg/dL or address dehydration, weakness, poor wound healing, or hyperglycemic crises; it also finds no significant increase in hospitalization for most infections at relaxed glycemic-control levels. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 36

  1. Holt RIG, Cockram CS, Ma RCW, Luk AOY. Diabetes and infection: review of the epidemio- logy, mechanisms and principles of treatment. Diabetologia 2024;67:1168-1180
  2. LeRoith D, Biessels GJ, Braithwaite SS, et al. Treatment of diabetes in older adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2019;104:1520-1574
  3. Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care 2018;41:2127-2135
  4. Boyko EJ, Fihn SD, Scholes D, Abraham L, Monsey B. Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women. Am J Epidemiol 2005;161:557-564
  5. Mor A, Dekkers OM, Nielsen JS, Beck-Nielsen H, Sørensen HT, Thomsen RW. Impact of glycemic control on risk of infections in patients with type 2 diabetes: a population-based cohort study. Am J Epidemiol 2017;186:227-236
  6. Zacay G, Hershkowitz Sikron F, Heymann AD. Glycemic control and risk of cellulitis. Diabetes Care 2021;44:367-372
  7. Bartelink ML, Hoek L, Freriks JP, Rutten GE. Infections in patients with type 2 diabetes in general practice. Diabetes Res Clin Pract 1998;40:15-19
  8. Hammar N, Farahmand B, Gran M, Joelson S, Andersson SW. Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials. Pharmacoepidemiol Drug Saf 2010; 19:1287-1292
  9. Boyko EJ, Fihn SD, Scholes D, Chen C-L, Normand EH, Yarbro P. Diabetes and the risk of acute urinary tract infection among postmenopausal women. Diabetes Care 2002;25:1778-1783
  10. Karter AJ, Parker MM, Moffet HH, et al. Missed appointments and poor glycemic control: an opportunity to identify high-risk diabetic patients. Med Care 2004;42:110-115
  11. Karter AJ, Schillinger D, Adams AS, et al. Elevated rates of diabetes in Pacific Islanders and Asian subgroups: the Diabetes Study of Northern California (DISTANCE). Diabetes Care 2012;36:574-579
  12. Harding JL, Benoit SR, Gregg EW, Pavkov ME, Perreault L. Trends in rates of infections requiring hospitalization among adults with versus without diabetes in the U.S., 2000-2015. Diabetes Care 2020;43:106-116
  13. McCoy RG, Lipska KJ, Herrin J, Jeffery MM, Krumholz HM, Shah ND. Hospital readmissions among commercially insured and Medicare advantage beneficiaries with diabetes and the impact of severe hypoglycemic and hyperglycemic events. J Gen Intern Med 2017;32:1097-1105
  14. Dobrzynski DM, Ndi DN, Zhu Y, Markus T, Schaffner W, Talbot HK. Hospital readmissions after laboratory-confirmed influenza hospitalization. J Infect Dis 2020;222:583-589
  15. Jensen AV, Faurholt-Jepsen D, Egelund GB, et al.; German Community-Acquired Pneumonia Competence Network (CAPNETZ). Undiagnosed diabetes mellitus in community-acquired pneumonia: a prospective cohort study. Clin Infect Dis 2017; 65:2091-2098
  16. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997;50: 105-116
  17. Grant RW, Schmittdiel JA, Neugebauer RS, Uratsu CS, Sternfeld B. Exercise as a vital sign: a quasi-experimental analysis of a health system intervention to collect patient-reported exercise levels. J Gen Intern Med 2014;29:341-348
  18. Bryson CL, Au DH, Sun H, Williams EC, Kivlahan DR, Bradley KA. Alcohol screening scores and medication nonadherence. Ann Intern Med 2008;149:795-804
  19. Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med 2004;36:588-594
  20. Messer LC, Laraia BA, Kaufman JS, et al. The development of a standardized neighborhood deprivation index. J Urban Health 2006;83:1041-1062
  21. Textor J, van der Zander B, Gilthorpe MS, Liskiewicz M, Ellison GT. Robust causal inference using directed acyclic graphs: the R package 'dagitty'. Int J Epidemiol 2016;45:1887-1894
  22. Carey IM, Critchley JA, DeWilde S, Harris T, Hosking FJ, Cook DG. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care 2018;41:513-521
  23. Breitling LP. Evidence of non-linearity in the association of glycemic control with influenza/ pneumonia mortality: a study of 19 000 adults from the US general population. Diabetes Metab Res Rev 2016;32:111-120
  24. Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab 2012;16 (Suppl. 1):S27-S36
  25. Peleg AY, Weerarathna T, McCarthy JS, Davis TME. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 2007;23:3-13
  26. Thaiss CA, Levy M, Grosheva I, et al. Hyper- glycemia drives intestinal barrier dysfunction and risk for enteric infection. Science 2018;359:1376-1383
  27. Tsai S-T, Lin F-Y, Chen P-S, Chiang H-Y, Kuo C-C. Three-year mortality in cryptococcal meningitis: hyperglycemia predict unfavorable outcome. PLoS One 2021;16:e0251749
  28. Donders GGG, Prenen H, Verbeke G, Reybrouck R. Impaired tolerance for glucose in women with recurrent vaginal candidiasis. Am J Obstet Gynecol 2002;187:989-993
  29. F€ ul€ op T, Dupuis G, Witkowski JM, Larbi A. The role of immunosenescence in the development of age-related diseases. Rev Invest Clin 2016;68: 84-91
  30. Gavazzi G, Krause K-H. Ageing and infection. Lancet Infect Dis 2002;2:659-666
  31. Rajagopalan S. Serious infections in elderly patients with diabetes mellitus. Clin Infect Dis 2005;40:990-996
  32. Pearson-Stuttard J, Blundell S, Harris T, Cook DG, Critchley J. Diabetes and infection: assessing the association with glycaemic control in population- based studies. Lancet Diabetes Endocrinol 2016;4: 148-158
  33. Hine JL, de Lusignan S, Burleigh D, et al. Association between glycaemic control and common infections in people with type 2 diabetes: a cohort study. Diabet Med 2017;34:551-557
  34. Ansari AS, de Lusignan S, Hinton W, Munro N, McGovern A. The association between diabetes, level of glycaemic control and eye infection: cohort database study. Prim Care Diabetes 2017;11:421-429
  35. American Geriatrics Society Expert Panel on Care of Older Adults with Diabetes Mellitus. Guidelines abstracted from the American Geriatrics Society guidelines for improving the care of older adults with diabetes mellitus: 2013 update. J Am Geriatr Soc 2013;61:2020- 2026
  36. Carey IM, Critchley JA, Chaudhry UAR, et al. Effects of long-term HbA1c variability on serious infection risks in patients with type 2 diabetes and the influence of age, sex and ethnicity: a cohort study of primary care data. Diabetes Res Clin Pract 2024;211:111641

Cited by

Sorted by citations

Authors
Lipska, K. J., Gilliam, L. K., Lee, C., Liu, J. Y., Liu, V. X., Moffet, H. H., Parker, M. M., Zapata, H., & Karter, A. J.
Affiliations
  • Yale University (US)
  • Kaiser Permanente South San Francisco Medical Center (US)
  • Kaiser Permanente (US)
Venue
Diabetes Care
Published
2024-10-22
Volume
47
Issue
12
Pages
2258-2265
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W4403637619
Cited by
7
References
1
Citations by year
2026: 3 · 2025: 4
FWCI
2.31
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • NIA (R01-AG063391, R56AG074986)
  • NIDDK (P30 DK092924)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
Keywords
type 2 diabetes, older adults, tight glycemic control, HbA1c, infection hospitalization, sepsis, respiratory infections, genitourinary infections, glycemic targets
MeSH terms
Glycemic Control, Aged, Aged, 80 and over, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Hospitalization, Humans, Infections, Male, Retrospective Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review